Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-12

FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)

View source ↗

Summary

FDA granted a supplemental approval for Furosemide by Phlow Corporation under the existing NDA; the snippet does not specify the exact nature of the supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)